載入...
Ramucirumab combined with paclitaxel as the second-line chemotherapy for elderly patients with disseminated gastric cancer
Gastric cancer is the third leading cause of cancer-related deaths worldwide. The prognosis of advanced gastric cancer remains poor despite therapeutic advances in recent decades. Several recent positive phase III trials established the efficacy of second-line chemotherapy for metastatic gastric can...
Na minha lista:
Main Authors: | , , , , |
---|---|
格式: | Artigo |
語言: | Russo |
出版: |
Remedium Group LLC
2018-07-01
|
叢編: | Медицинский совет |
主題: | |
在線閱讀: | https://www.med-sovet.pro/jour/article/view/2553 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
載入...